Pembrolizumab in Untreated Extensive SCLC
Clinical trial NCT02580994 · COMPLETED
Trial details
- NCT number
- NCT02580994
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-08
- Primary completion
- 2020-09-22
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.